-- Won International Award for Outstanding Research Published in Journal, Nutrition: In September 2008, the researchers at Interleukin Genetics received the 12th John M. Kinney Award for Nutrition and Metabolism at the annual Congress of the European Society of Parenteral and Enteral Nutrition in Florence, Italy. The award was given for the paper, "Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept."
-- Presented findings at 2008 World Congress on Osteoarthritis: In September 2008, Kenneth Kornman, Ph.D., the Company's Chief Scientific Officer, presented important new research findings on the genetics of osteoarthritis (OA) in Rome, demonstrating that Interleukin Genetics' genetic test appears to identify knee OA patients likely to develop more severe joint destruction as they age.
-- Enhanced Heart Health Genetic Test Report Format: In July 2008, the Company launched an enhanced test report format and information package for the company's Heart Health Genetic Test, currently marketed under the brand name Gensona(R) by Amway Global. The new report includes quantified risk information on heart attack and coronary artery disease generated from clinical studies and provides individuals and their physicians with more complete information about a person's inflammation-based genetic risk for a heart attack, along with preventive measure guidance and scientific educational materials.
-- Expanded Board of Directors: In July 2008, the Company added three new directors to the Board: Mary E. Chowning, Glenn S. Armstrong, Ph.D., and Chief Executive Officer Lewis H. Bender. Ms. Chowning also will serve as the Chairperson of the Audit Committee of the Board.
Conference Call and Webcast Information
Interleukin Genetics will host a live conference call and webcast today
at 4:30 pm. ET. To access the live call
|SOURCE Interleukin Genetics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved